Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705301 · ClinicalTrials.gov registry record
Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 36
- Enrollment target
NCT01705301: Completed study, sponsored by Mayo Clinic.
NCT01705301 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01705301 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
In this study, the investigators will monitor extracellular neurotransmitter levels using a probe that is able to perform real time electrochemical detection during deep brain stimulation surgery. The overall question this study is designed to answer is: Are there neurotransmitters released during deep brain stimulation?
Primary Outcome
Pre, during, post DBS (deep brain stimulation)
Interventions
- DEVICE WINCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-01 |
| Est. Completion | 2017-07-27 |
What the finished NCT01705301 record still lists
NCT01705301 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which WINCS is the first listed.
NCT01705301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01705301 about?
NCT01705301 is a clinical study titled "Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery". In this study, the investigators will monitor extracellular neurotransmitter levels using a probe that is able to perform real time electrochemical detection during deep brain stimulation surgery. The overall question this study is designed to answer is: Are there neurotransmitters released during d...
What is the current status of trial NCT01705301?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2010-01. Estimated completion is 2017-07-27.
What interventions are being tested in trial NCT01705301?
The interventions under investigation include: WINCS (DEVICE).
Who is sponsoring clinical trial NCT01705301?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia